-
Featured
Medical Grand Rounds: The Omicron Surge: Testing, Clinical Aspects, Vaccines, and Global Implications
Ruanne Barnabas, MBChB, MSc, DPhil, chief of the Division of Infectious Diseases at Massachusetts General Hospital, and members of the Boston medical community discuss clinical aspects and global implications of the omicron surge.
-
Featured
Severe Allergic Reactions Are Rare with COVID-19 mRNA Vaccines
A prospective study of employee mRNA COVID-19 vaccination at Mass General Brigham linked self-reported history of high-risk allergy to increased risk of self-reported allergic reactions, but only 0.3% of employees had severe reactions and the vast majority completed the two-dose series.
-
Featured
Prolonged Symptoms Rare in College Athletes Following SARS-CoV-2 Infection, However, Exertional Chest Pain After Infection Warrants Further Evaluation
Using a nationwide registry, cardiologists at Massachusetts General Hospital determined that few college athletes who develop SARS-CoV-2 infection have prolonged symptoms, but exertional symptoms on return to exercise, especially chest pain, warrant clinical evaluation and consideration of cardiac MRI to assess for inflammatory heart disease.
-
In Utero Exposure to SARS-CoV-2 May Increase the Risk of Cardiometabolic Disease
Massachusetts General Hospital researchers found that infants who have in utero exposure to maternal SARS-CoV-2 exhibit lower birth weight followed by accelerated weight gain in the first year of life, a pattern thought to increase the risk of obesity and cardiometabolic disease in childhood and adulthood.
-
Prior Disability Prevention Training Promoted Resilience of Racially and Ethnically Minoritized Older Adults During COVID-19
Margarita Alegría, PhD, and colleagues previously found that six months of psychosocial and exercise training for vulnerable older adults improved mood and physical function compared with enhanced usual care. They provide evidence that some effects persisted for two to six years—despite the COVID-19 pandemic.
-
COVID-19 Vaccination Is Protective, Well Tolerated in Cancer Patients
Vivek Naranbhai, MBchB, PhD, DPhil, and colleagues found in an analysis of prospective data that COVID-19 vaccines are well tolerated in patients with cancer and most recipients are likely to be protected against severe disease, although non-mRNA vaccines and some therapies may impair responses.
COVID-19 Expert Contributors
-
Andrea Edlow, MD, MSc
Maternal-Fetal Medicine Specialist , Investigator, Vincent Center for Reproductive Biology
Recent Article
In Utero Exposure to SARS-CoV-2 May Increase the Risk of Cardiometabolic Disease
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Persistent Dyspnea After COVID-19 May Have Another Cause
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Elizabeth M. Van Cott, MD
Director, Coagulation Laboratory, Massachusetts General Hospital, Professor of Pathology, Harvard Medical School
Recent Article
Pronounced Elevation of Factor V in Severe COVID-19 Is Associated with Venous Thromboembolism -
Erica Seiguer Shenoy, MD, PhD
Associate Physician, Massachusetts General Hospital, Associate Chief of the Infection Control Unit, Massachusetts General Hospital
Recent Article
Diagnostic Algorithm Supports Evaluation of Hospitalized COVID-19 Patients After Initial Negative Test
-
Galit Alter, PhD
Principal Investigator, Ragon Institute, Massachusetts General Hospital, Samana Cay MGH Research Scholar
Recent Article
Dysregulated Antibody Response Implicated in Severe COVID-19 in Adults and Multisystem Inflammatory Syndrome in Children
-
George A. Alba, MD
Pulmonary and Critical Care Physician, Instructor of Medicine at Harvard Medical School
Recent Article
Mass General Pulmonologist Explores Role of NEDD9 in ARDS
-
Hanny Al-Samkari, MD
Hematologist
Recent Article
Trial Co-led by Mass General Leads to Oral Drug Approval for Red Blood Cell Disorder
-
Ilona T. Goldfarb, MD, MPH
Maternal Fetal Medicine Specialist, Massachusetts General Hospital
Recent Article
Understanding of Sociocognitive Theory Can Improve Medical Student Training
-
Katrina A. Armstrong, MD
Former Physician-in-Chief, Department of Medicine, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: Outpatient COVID-19 Therapies in the Time of Omicron
-
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Inhaled Nitric Oxide Improves Oxygenation in Pregnant Patients With COVID-19 Pneumonia
-
Louise C. Ivers, MD
Interim Director of the Division of Infectious Diseases, Executive Director of the Mass General Center for Global Health
-
Michael L. Dougan, MD, PhD
Physician, Division of Gastroenterology, Massachusetts General Hospital, Director, GI Center for Cancer Complications, Mass General Cancer Center, Preclinical Education Group Leader, Associate Professor of Medicine, Harvard Medical School
Recent Article
Concurrent Immunosuppressive Therapy With Restart of Checkpoint Inhibitor Reduces Risk of Recurrent Immune-related Enterocolitis
-
Rachel P. Rosovsky, MD
Hematologist, PERT Executive Committee Member
Recent Article
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19
-
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.